Cargando…
Novel Therapies for Diabetic Kidney Disease: Storied Past and Forward Paths
IN BRIEF Current therapeutic approaches are only moderately efficacious at preventing the progression of diabetic kidney disease (DKD). As the number of people with DKD continues to rise worldwide, there is an urgent need for novel therapies. A better understanding of the root causes and molecular m...
Autores principales: | Dieter, Brad P., Alicic, Radica Z., Meek, Rick L., Anderberg, Robert J., Cooney, Sheryl K., Tuttle, Katherine R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536640/ https://www.ncbi.nlm.nih.gov/pubmed/26300609 http://dx.doi.org/10.2337/diaspect.28.3.167 |
Ejemplares similares
-
Glycemic Variability and KIM-1–Induced Inflammation in the Diabetic Kidney
por: Tuttle, Katherine R., et al.
Publicado: (2021) -
Erratum. Sodium–Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease. Diabetes 2019;68:248–257
por: Alicic, Radica Z., et al.
Publicado: (2019) -
Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease
por: Alicic, Radica Z., et al.
Publicado: (2023) -
Serum amyloid A and Janus kinase 2 in a mouse model of diabetic kidney disease
por: Dieter, Brad P., et al.
Publicado: (2019) -
Serum amyloid A and inflammation in diabetic kidney disease and podocytes
por: Anderberg, Robert J, et al.
Publicado: (2015)